Details for New Drug Application (NDA): 020768
✉ Email this page to a colleague
The generic ingredient in ZOMIG is zolmitriptan. There are twenty drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 020768
Tradename: | ZOMIG |
Applicant: | Ipr |
Ingredient: | zolmitriptan |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | Nov 25, 1997 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 25, 1997 | TE: | RLD: | Yes |
Expired US Patents for NDA 020768
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | 5,466,699*PED | ⤷ Subscribe |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | 5,863,935*PED | ⤷ Subscribe |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-002 | Nov 25, 1997 | 5,466,699*PED | ⤷ Subscribe |
Ipr | ZOMIG | zolmitriptan | TABLET;ORAL | 020768-001 | Nov 25, 1997 | 5,863,935*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription